Caveolin-1 (CAV1), another significant regulator identified in the NAS treatment, facilitates endocytosis and regulates cell metabolism such as modulation of glycolytic activities, mitochondrial functions, fatty acid metabolism, cholesterol distribution, and insulin signaling in normal and cancer cells36,37. This evidence concerns the gene CAV1 and cancer.